Directory
>
Claire Neilan
Claire Neilan
Vice President, and Head, Pharmacology and Toxicology | IDEAYA Biosciences
United States
Claire Neilan
Summary
Claire Neilan is a seasoned Vice President of Preclinical Sciences at IDEAYA Biosciences, bringing over 20 years of experience in the pharmaceutical industry. She is a board-certified toxicologist with a robust background in nonclinical drug development, particularly in oncology. Claire has played a pivotal role in the pharmacology and nonclinical safety testing strategies for a diverse portfolio of small molecule oncology drugs. Her leadership experience includes being the Lead Toxicologist on four marketed products and overseeing approximately 15 IND submissions, showcasing her expertise in regulatory interactions. Claire has held various senior roles at prominent organizations, including Gilead Sciences and Incyte, where she contributed significantly to toxicology and pharmacology. With a PhD in Pharmacology and a BSc in Medicinal and Pharmaceutical Chemistry from Loughborough University, she combines academic excellence with practical industry knowledge. Her career reflects a commitment to advancing drug development and safety, making her a valuable asset in the life sciences sector.
Claire Neilan
Work Experience
Vice President, and Head, Pharmacology and Toxicology at
IDEAYA Biosciences
March 2021 - Present
Senior Director and Head, Pharmacology and Toxicology at
IDEAYA Biosciences
March 2020 - March 2021
Senior Director, Preclinical Sciences at
IDEAYA Biosciences
August 2019 - February 2020
Director, Preclinical Sciences at
IDEAYA Biosciences
November 2017 - July 2019
Senior Research Scientist, Nonclinical Safety And Pathobiology at
Gilead Sciences Austria
January 2015 - November 2017
Director, Toxicology at
Incyte
August 2013 - January 2015
Associate Director, Toxicology at
Incyte
August 2010 - August 2013
Principal Research Investigator, Toxicology at
Incyte
February 2007 - August 2010
Senior Research Investigator at
Incyte
February 2004 - February 2007
Postdoctoral Research Fellow at
Incyte
January 2003 - December 2003
Research Fellow (post-doc) at
Memorial Sloan Kettering Cancer Center
January 2000 - December 2002
Visiting Research Student at
University of Michigan Medical Center
May 1997 - December 1999
Claire Neilan
Education
January 1995 - January 2000
Loughborough University, Bsc (Hons)
January 1991 - January 1995
Frequently Asked Questions about Claire Neilan
What is Claire Neilan email address?
Claire Neilan's primary email address is *******@ideayabio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Claire Neilan work for?
Claire Neilan is a Vice President, and Head, Pharmacology and Toxicology at IDEAYA Biosciences, a company specializing in Commercial physical research.
Where Claire Neilan graduated from?
Claire Neilan holds a degree in Pharmacology from Loughborough University.
How can I directly contact Claire Neilan?
To contact Claire Neilan directly, you can use the email address *******@ideayabio.com. Complete contact information is available upon registration with Muraena.
Who is Claire Neilan?
Claire Neilan is a seasoned Vice President of Preclinical Sciences at IDEAYA Biosciences, bringing over 20 years of experience in the pharmaceutical industry. She is a board-certified toxicologist with a robust background in nonclinical drug development, particularly in oncology. Claire has played a pivotal role in the pharmacology and nonclinical safety testing strategies for a diverse portfolio of small molecule oncology drugs. Her leadership experience includes being the Lead Toxicologist on four marketed products and overseeing approximately 15 IND submissions, showcasing her expertise in regulatory interactions. Claire has held various senior roles at prominent organizations, including Gilead Sciences and Incyte, where she contributed significantly to toxicology and pharmacology. With a PhD in Pharmacology and a BSc in Medicinal and Pharmaceutical Chemistry from Loughborough University, she combines academic excellence with practical industry knowledge. Her career reflects a commitment to advancing drug development and safety, making her a valuable asset in the life sciences sector.
Claire`s contact details
*******@ideayabio.com
Colleagues
Chief Technology Officer, Head of Drug Discovery
Senior Vice President, Head of Development Operations
Chief Scientific Officer
VP and Head of Medicinal Chemistry
Chief Medical Officer
Vice President Early Oncology Clinical Development
Vice President, Head of CMC
Vice President, Clinical Operations
Senior Vice President, Head of Finance and Investor Relations